Nabla Bio
We use AI to design antibodies for intractable diseases
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
- Category
- Analytics
- Pricing
- freemium
- Difficulty
- beginner
Y Combinator batch: Summer 2020
Directory records are starting points for research. Check the official website for current features, pricing and availability. A catalog sync is not a hands-on product review.
Features
- AI-Powered
- API Access
- Content Generation
Industries
- Healthcare